investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Zhiyuan Shen
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yuntao Xie
Beijing Cancer Hospital
Beijing, China
Zhiyuan Shen
Rutgers University
New Brunswick, United States
Related projects
Agata Smogorzewska
The role of nucleases in interstrand crosslink repair
Breast
James K Chen
Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation
Non-Melanoma skin cancer
Brain, nervous system
C Marcelo Aldaz
Characterization of WWOX, the Cancer Gene Spanning FRA16D
Breast
Bing Xia
Targeting Autophagy in Hereditary Breast Cancer
Breast
Leo Masamba
Breast Cancer Receptor Study : Targeting HIV Associated Lymphoma in Malawi
Breast
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Breast
Maria Jasin
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Susan L Mooberry
Taccalonolides: Mechanisms of Action and Cellular Resistance
Breast